American Journal of Roentgenology, Vol 158, 183-190, Copyright © 1992 by American Roentgen Ray Society

ARTICLES

MR lymphography with iron oxide particles: dose-response studies and pulse sequence optimization in rabbits

B Hamm, M Taupitz, P Hussmann, S Wagner and KJ Wolf
Department of Radiology, Klinikum Steglitz, Freie Universitat Berlin, Germany.

Superparamagnetic iron oxide (SPIO) particles are a promising contrast agent for MR lymphography. The effect of SPIO on MR imaging of normal lymph nodes and the impact of the size of the dose have not yet been investigated in detail. Therefore, we performed dose-response and pulse sequence optimization studies. MR images of the iliac lymph nodes of 15 normal rabbits were obtained at 1.5 T with 12 different spin-echo (SE) and gradient-echo (GRE) sequences before and after SPIO administration. The contrast agent was injected into a femoral lymph vessel at five different doses (0.02-2.0 mumol Fe/animal). The dose that reduced signal intensity by half (ED50) was determined for each sequence, and images were evaluated qualitatively. Doses of 0.2 and 1.0 mumol Fe caused a complete signal loss throughout the lymph node. In this dose range, proton density-weighted SE sequences showed a profound signal loss (ED50, 0.132 mumol Fe), and lymph nodes were sharply demarcated. The GRE sequences (ED50, 0.027-0.070 mumol Fe) and the T2-weighted SE sequence (ED50, 0.014 mumol Fe) showed an even more pronounced signal loss but insufficient anatomic resolution. Underdosing (less than or equal to 0.1 mumol Fe) caused only a focal signal loss in the lymph nodes. Oversaturation (2.0 mumol Fe for SE sequences, greater than or equal to 1.0 mumol Fe for GRE sequences) led to image distortion and did not allow assessment of lymph node morphology. Our results show that optimal contrast enhancement of normal lymph nodes with SPIO can be achieved in the dose range of 0.2-1.0 mumol Fe on proton density- weighted SE sequences. Our results may serve as a basis for further development of noninvasive MR lymphography.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Anzai, C. W. Piccoli, E. K. Outwater, W. Stanford, D. A. Bluemke, P. Nurenberg, S. Saini, K. R. Maravilla, D. E. Feldman, U. P. Schmiedl, et al. Evaluation of Neck and Body Metastases to Nodes with Ferumoxtran 10-enhanced MR Imaging: Phase III Safety and Efficacy Study Radiology, September 1, 2003; 228(3): 777 - 788. [Abstract] [Full Text] [PDF]

				H. Kobayashi, S. Kawamoto, R. A. Star, T. A. Waldmann, Y. Tagaya, and M. W. Brechbiel Micro-magnetic Resonance Lymphangiography in Mice Using a Novel Dendrimer-based Magnetic Resonance Imaging Contrast Agent Cancer Res., January 15, 2003; 63(2): 271 - 276. [Abstract] [Full Text] [PDF]

				G. Staatz, C. C. A. Nolte-Ernsting, G. B. Adam, S. Grosskortenhaus, B. Misselwitz, A. Bucker, and R. W. Gunther Interstitial T1-weighted MR Lymphography: Lipophilic Perfluorinated Gadolinium Chelates in Pigs Radiology, July 1, 2001; 220(1): 129 - 134. [Abstract] [Full Text] [PDF]

				M. G. Mack, J. O. Balzer, R. Straub, K. Eichler, and T. J. Vogl Superparamagnetic Iron Oxide-enhanced MR Imaging of Head and Neck Lymph Nodes Radiology, January 1, 2002; 222(1): 239 - 244. [Abstract] [Full Text] [PDF]